Hint mode is switched on Switch off

Glenmark Pharmaceuticals, ordinary share
GLENMARK, INE935A01035

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access
Add a stock to WL
Choose all Reset all
Glenmark Pharmaceuticals, сountry — India
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Dividends

Issuer

Profile
Glenmark Pharmaceuticals is a pharmaceutical company headquartered in Mumbai, India. It manufactures and markets generic formulation products and active pharmaceutical ingredients (API), both in the domestic and international markets. In the formulation business, its business spans ...
Glenmark Pharmaceuticals is a pharmaceutical company headquartered in Mumbai, India. It manufactures and markets generic formulation products and active pharmaceutical ingredients (API), both in the domestic and international markets. In the formulation business, its business spans segments such as Dermatology, Internal Medicine, Paediatrics, Gynaecology, ENT and Diabetes.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    Glenmark Pharmaceuticals Ltd
  • Industry
    Pharmaceutical Preparation and Biotechnology

Indicators

News

26/07/2016 New bond issue: Glenmark Pharmaceuticals issued international bonds for USD 200.0m maturing in 2021 with a 4.5% coupon.
26/07/2016 New bond issue: Glenmark Pharmaceuticals issued international bonds for USD 200.0m maturing in 2021 with a 4.5% coupon.
02/06/2016 New bond issue: Glenmark Pharmaceuticals will issue international bonds for USD 170.0m maturing in 2022 with a 2% coupon.
All organization news

Holders

Industry Leaders

Registration is required to get access.